过度表达DPF2与免疫透和肝细胞癌的不良预后相关

Kejian Yang1,2,3, Jusen Nong1,2,3, Haixiang Xie1,2,3

  • 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.

Journal of Cancer
|July 15, 2024
PubMed
概括

双植物家庭主体指2 (DPF2) 在肝细胞癌 (HCC) 中升高,与预后不佳和免疫逃避相关. DPF2显示出作为HCC的诊断和预后生物标志物的潜力.